Case Study Analysis and Solutions

Case ID: 814023

Abstract:
Case Solution & Analysis for MedImmune Ventures by Richard G. Hamermesh, David Lane
Ron Laufer is the new Senior Managing Director of MedImmune Ventures', the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer will make will reflect his vision for MedImmune Ventures and more broadly the incentives he faces as a corporate venture capitalist.

Keywords:
Venture capital, MedImmune Ventures Case Solution

Click Here to place your order

OR

Contact us directly at ordercasesolutions@gmail.com if you want to solve the above case.